Form 13-F position report

GILEAD SCIENCES INC

Reported by PRUDENTIAL PLC

GILD 1.625 05/01/16 D CUSIP 375558AP8 Manager CIK 0000898419

Reported 0 shares, down 2,329,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2014
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 7 Through Q4 2014

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for GILEAD SCIENCES INC held by PRUDENTIAL PLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

74 managers reported GILEAD SCIENCES INC for Q4 2014.

Managers reporting GILEAD SCIENCES INC in Q4 2014.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BLACKROCK ADVISORS LLC Reduced 28,738,000 -13,352,000 0.12% $118,939,000 7 qtrs
LOOMIS SAYLES & CO L P Added 1,146,213 +48,138 0.3% $108,043,000 7 qtrs
WELLS FARGO & COMPANY MN Reduced 25,698,000 -9,868,000 0.04% $106,359,000 7 qtrs
BAKER BROS ADVISORS LP Unchanged 21,500,000 0 0.91% $88,977,000 7 qtrs
AXA S A Unchanged 0 0 0.31% $76,567,000 7 qtrs
Calamos Advisors LLC Reduced 17,983 -9,695 0.49% $74,483,000 7 qtrs
MACKAY SHIELDS LLC Reduced 17,002,000 -111,000 3.63% $70,395,000 3 qtrs
VICTORY CAPITAL MANAGEMENT INC Reduced 15,998,456 -1,429,780 0.24% $66,213,000 6 qtrs
UBS ASSET MANAGEMENT AMERICAS INC Reduced 15,705,000 -3,000,000 0.06% $65,338,000 7 qtrs
ADVENT CAPITAL MANAGEMENT DE Added 15,506,000 +1,774,000 0.94% $64,205,000 7 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2014
Filed
February 13, 2015
Filing type
13F-HR
Position type
1.625% CNV SNR 01/05/16 USD

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.